Evrofarma SA reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 36.7 million compared to EUR 33.91 million a year ago. Net loss was EUR 0.355 million compared to net income of EUR 1.06 million a year ago. Basic loss per share from continuing operations was EUR 0.026 compared to basic earnings per share from continuing operations of EUR 0.0775 a year ago.